121 related articles for article (PubMed ID: 2926498)
1. O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts.
Schold SC; Brent TP; von Hofe E; Friedman HS; Mitra S; Bigner DD; Swenberg JA; Kleihues P
J Neurosurg; 1989 Apr; 70(4):573-7. PubMed ID: 2926498
[TBL] [Abstract][Full Text] [Related]
2. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair.
Souliotis VL; Kaila S; Boussiotis VA; Pangalis GA; Kyrtopoulos SA
Cancer Res; 1990 May; 50(9):2759-64. PubMed ID: 2328502
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations, O6-alkylguanine DNA alkyltransferase activity, and sensitivity to procarbazine in human brain tumors.
Russell SJ; Ye YW; Waber PG; Shuford M; Schold SC; Nisen PD
Cancer; 1995 Mar; 75(6):1339-42. PubMed ID: 7882284
[TBL] [Abstract][Full Text] [Related]
5. Tumour levels of O6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts.
Tagliabue G; Citti L; Massazza G; Damia G; Giavazzi R; D'Incalci M
Anticancer Res; 1992; 12(6B):2123-5. PubMed ID: 1295458
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme.
Friedman HS; Dolan ME; Moschel RC; Pegg AE; Felker GM; Rich J; Bigner DD; Schold SC
J Natl Cancer Inst; 1992 Dec; 84(24):1926-31. PubMed ID: 1334154
[TBL] [Abstract][Full Text] [Related]
7. Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Felker GM; Friedman HS; Dolan ME; Moschel RC; Schold C
Cancer Chemother Pharmacol; 1993; 32(6):471-6. PubMed ID: 8258196
[TBL] [Abstract][Full Text] [Related]
8. Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.
Dolan ME; Stine L; Mitchell RB; Moschel RC; Pegg AE
Cancer Commun; 1990; 2(11):371-7. PubMed ID: 2242301
[TBL] [Abstract][Full Text] [Related]
9. Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.
Dolan ME; Larkin GL; English HF; Pegg AE
Cancer Chemother Pharmacol; 1989; 25(2):103-8. PubMed ID: 2557168
[TBL] [Abstract][Full Text] [Related]
10. O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.
Wedge SR; Newlands ES
Br J Cancer; 1996 May; 73(9):1049-52. PubMed ID: 8624262
[TBL] [Abstract][Full Text] [Related]
11. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.
Friedman HS; Johnson SP; Dong Q; Schold SC; Rasheed BK; Bigner SH; Ali-Osman F; Dolan E; Colvin OM; Houghton P; Germain G; Drummond JT; Keir S; Marcelli S; Bigner DD; Modrich P
Cancer Res; 1997 Jul; 57(14):2933-6. PubMed ID: 9230204
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of procarbazine and methylnitrosourea on the accumulation of O6-methylguanine and the depletion and recovery of O6-alkylguanine-DNA alkyltransferase in rat tissues.
Valavanis C; Souliotis VL; Kyrtopoulos SA
Carcinogenesis; 1994 Aug; 15(8):1681-8. PubMed ID: 7519972
[TBL] [Abstract][Full Text] [Related]
13. Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine.
Souliotis VL; Valavanis C; Boussiotis VA; Pangalis GA; Kyrtopoulos SA
Carcinogenesis; 1994 Aug; 15(8):1675-80. PubMed ID: 8055650
[TBL] [Abstract][Full Text] [Related]
14. O6-methylguanine-DNA methyltransferase activity in cerebral gliomas. A guidance for nitrosourea treatment?
Mineura K; Izumi I; Kuwahara N; Kowada M
Acta Oncol; 1994; 33(1):29-32. PubMed ID: 8142120
[TBL] [Abstract][Full Text] [Related]
15. O6-alkylguanine-DNA alkyltransferase activity in human brain tumors.
Mineura K; Izumi I; Watanabe K; Kowada M
Tohoku J Exp Med; 1991 Nov; 165(3):223-8. PubMed ID: 1807009
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
Friedman HS; Pegg AE; Johnson SP; Loktionova NA; Dolan ME; Modrich P; Moschel RC; Struck R; Brent TP; Ludeman S; Bullock N; Kilborn C; Keir S; Dong Q; Bigner DD; Colvin OM
Cancer Chemother Pharmacol; 1999; 43(1):80-5. PubMed ID: 9923545
[TBL] [Abstract][Full Text] [Related]
17. Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.
Dolan ME; Morimoto K; Pegg AE
Cancer Res; 1985 Dec; 45(12 Pt 1):6413-7. PubMed ID: 4063990
[TBL] [Abstract][Full Text] [Related]
18. Contribution of O6-methylguanine-DNA methyltransferase to monofunctional alkylating-agent resistance in human brain tumor-derived cell lines.
Bobola MS; Blank A; Berger MS; Silber JR
Mol Carcinog; 1995 Jun; 13(2):70-80. PubMed ID: 7605582
[TBL] [Abstract][Full Text] [Related]
19. A novel, sensitive assay for O6-methyl- and O6-ethylguanine in DNA, based on repair by the enzyme O6-alkylguanine-DNA-alkyltransferase in competition with an oligonucleotide containing O6-methylguanine.
Souliotis VL; Kyrtopoulos SA
Cancer Res; 1989 Dec; 49(24 Pt 1):6997-7001. PubMed ID: 2684406
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the rates of repair of O6-alkylguanines in DNA by rat liver and bacterial O6-alkylguanine-DNA alkyltransferase.
Pegg AE; Scicchitano D; Dolan ME
Cancer Res; 1984 Sep; 44(9):3806-11. PubMed ID: 6378375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
